20 September 2019
Visiongain has launched a new pharma report Global Diagnostic Imaging Market Forecast 2019-2029: MRI Systems, Ultrasound Imaging Systems, CT Scanners, Nuclear Imaging, X-Ray Imaging, Mammography, Cardiology, Gynecology/Obs, Orthopaedics & Musculoskeletal, Radiology, Neurology & Spine, General Imaging, Hospitals, Diagnostic Imaging Centers.
Diagnostic imaging is an integral part of treatment decisions and also plays a role in therapy planning, therapy monitoring and follow-up.
The lead analyst of the report commented "Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine. Currently, many of the diagnostic imaging devices are powered by artificial intelligence and machine learning. This would significantly improve diagnostic quality, efficiency, and treatment patterns.
The high cost associated with the clinical trials and development of diagnostic imaging devices coupled with the inefficient infrastructure is likely to impede the growth of the diagnostic imaging market."
Leading companies featured in the report include Canon, Inc., Carestream Health, Inc., Esaote SPA, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V. (Royal Philips), Samsung Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.